The present invention provides a TGR5 receptor agonist comprising a fused ring compound represented by the formula
wherein ring A is an optionally substituted aromatic ring; and ring B′ is a 5- to 8-membered ring having one or more substituents or a salt thereof or a prodrug thereof, which is useful for the treatment of various diseases.
本发明提供了一种
TGR5受体激动剂,包括由下式表示的融合环化合物:其中环A是可选取代的芳香环;环B'是具有一种或多种取代基的5-至8-成员环,或其盐或前药,用于治疗各种疾病。